Selected Publications
Elghawy O, Barsouk A, Xu J, Chen S, Cohen RB, Sun L.: Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma Eur Thyroid J : 2024.
Elghawy O, Barsouk A, Heidlauf A, Chen S, Cohen RB, Sun L.: Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma J Endocr Soc 8 : bvae158,2024.
Tompkins W, Grady CB, Hwang WT, Chandrasekhara K, McCoach C, Sun F, Liu G, Patel D, Nieva J, Herrmann A, Marrone K, Lam VK, Velcheti V, Liu SV, Montenegro GLB, Patil T, Weiss J, Miller KL, Schwartzman W, Dowell JE, Shaverdashvili K, Villaruz L, Cass A, Iams W, Aisner D, Aggarwal C, Camidge DR, Marmarelis ME, Sun L.: Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC JTO Clin Res Rep 5 : 100669,2024.
Sun L, Handorf EA, Zhou Y, Borghaei H, Aggarwal C, Bauman J.: Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels Lung Cancer : 2024.
Stalker M, …Sun L, Marmarelis M: Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated Non-Small Cell Lung Cancer: An ATOMIC Registry Analysis. JTO Clin Res Rep. : 2024.
Stalker M, Qu K, Hwang WT, Cohen RB, Mamtani R, Sun L: “Off-label” use of checkpoint inhibitor in patients with PD-L1 negative or unknown advanced head and neck cancer JNCCN : 2024.
Stalker M, Marmarelis M, Langer C, Cohen RB, Singh A, Aggarwal C, Sun L.: Outcomes following treatment for progression in patients treated with durvalumab consolidation in LA-NSCLC. Clinical Lung Cancer : 2024.
Sun L, Brody R, Candelieri D, Lynch JA, Cohen RB, Li Y, Getz KD, Ky B.: Risk of Cardiovascular Events Among Patients With Head and Neck Cancer JAMA Otolaryngol Head Neck Surg 149 : 717-725,2023.
Sun L, Ky, Bonnie.: Cardiovascular risk and events in US Veterans with head and neck squamous cell carcinoma JAMA Otolaryngology Head Neck Surg 149 (8): 717-725,2023.
Sun L, Bleiberg B, Hwang WT, Marmarelis ME, Langer CJ, Singh A, Cohen RB, Mamtani R, Aggarwal C.: Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer JAMA Oncol 9 : 1075-1082,2023.
Academic Contact Information
Perelman Center for Advanced Medicine
10 South Pavilion
3400 Civic Center Blvd
Philadelphia,
PA
19104
Patient appointments: 800-789-7366